New drug research in autism on the compound Cellceutix KM-391 results in significant behavior changes; Editor … Cellceutix Corporation (OTCBB: CTIX) announced today that a new animal study of its compound autism spectrum disorders, KM-391, once again demonstrated a positive impact on several measures of behavior associated with autism. As announced last week, accelerated Cellceutix research through a collaborative effort with InteRed Faculty of Clinical Research (IFRC) in India and the prestigious …
Understanding Autism

Tags: autism, brain, neuroscience, psychology, research

This entry was posted on August 28, 2009 at 4:10 pm. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Posted in Autism and You by admin No Comments Yet